Cardiac history
Prepare a complete account of heart conditions, fainting, palpitations, family history of sudden cardiac death, and prior cardiac testing. A provider should be willing to explain how that history affects eligibility.
For U.S.-based adults considering overseas access
Overseas Clinic Checklist
A practical, evidence-based set of questions for evaluating ibogaine treatment abroad—before travel, before payment, and before any decision is made under pressure.
In the United States, ibogaine is a Schedule I controlled substance. There are no licensed domestic ibogaine treatment centers, and using underground U.S. providers carries legal and safety risks. The DEA’s drug scheduling overview explains the federal classification framework; this page focuses on careful questions for people considering options outside the country.
Before booking travel
Start with medical screening
Any prospective provider should make screening a condition of proceeding, not a last-minute administrative step. Ask what happens when screening raises a concern—and whether the answer is a clear pause rather than a sales conversation.
ECG before any decision
Ask whether a recent ECG is required, who reviews it, and what findings would stop treatment. The published cardiac safety review is a useful prompt for discussing ibogaine-associated QT concerns rather than treating an ECG as a formality.
Medication review
Provide a current medication and supplement list, including recent changes. Ask specifically which medicines may contraindicate ibogaine, how interactions are assessed, and whether a safe medication-change plan requires coordination with an existing prescriber.
Health information in writing
Request the screening requirements before travel. A clinic that cannot describe its process in writing leaves you unable to compare basic safeguards. For broader context on international access questions, treatment location considerations can help keep geography separate from evidence of preparedness.
Questions for a prospective clinic
Look for protocols, not reassurance
Who is medically responsible on site?
Ask what medical staff are present during dosing and monitoring, what credentials they hold in the country where the clinic operates, and how responsibilities are divided. Vague labels should not substitute for a direct answer.
What is the emergency plan?
Ask whether oxygen and a defibrillator are available, who can use them, what the written escalation protocol says, and how ICU or hospital transfer would occur if needed. The FDA’s warning about ibogaine risks is a reminder that emergency capacity should be discussed concretely.
What does informed consent cover?
Request the consent materials early. They should explain known risks, limits of evidence, alternatives, privacy practices, what care is and is not included, and what happens if treatment is deferred after arrival. A separate guide to evaluating clinic claims can help distinguish documented answers from promotional language.
Signals to pause
Red flags are decision information
A persuasive story, a polished website, or a promised outcome cannot replace documented screening and emergency planning. If an answer is evasive, treat that absence as information.
No ECG requirement
A clinic that does not require or clearly discuss an ECG before proceeding is not describing a cautious cardiac-screening process.
No written protocol
Refusal or inability to share screening, emergency, medication-review, or consent procedures in writing makes informed comparison difficult.
Cash-only pressure
Insistence on cash-only payment, especially when paired with urgency or reluctance to document terms, is a reason to slow down and reconsider.
No follow-up plan
If no aftercare or follow-up is discussed, ask how a clinic understands its responsibilities once a visitor returns to the United States.
Return planning
Arrange support after travel
Before departure, identify what support will be available on return and what information can be shared with an existing clinician or trusted support person. A clinic’s plan should describe follow-up, not merely the travel period itself.
- Ask who will provide follow-up, how contact occurs, and how long it is offered.
- Clarify whether there is a written discharge summary and how medication questions are handled after return.
- Consider practical continuity: lodging, travel readiness, a trusted companion where appropriate, and a realistic plan for the days after arrival home.
Practical questions
Keep the decision grounded
These questions do not replace medical or legal advice. They can help a prospective traveler identify missing information before making commitments.
Are there licensed ibogaine treatment centers in the United States?
No. Ibogaine is controlled federally in the United States, and there are no licensed domestic ibogaine treatment centers. Underground U.S. providers carry legal and safety risks. Information about Florida treatment claims, Texas treatment options, and Texas policy discussions should not be read as proof that a U.S. facility is licensed or medically equipped.
What should a clinic provide before travel?
A prospective clinic should be able to describe screening, medication review, cardiac assessment, emergency escalation, informed consent, and follow-up arrangements in writing. It should also be able to answer direct questions about staff roles and transfer arrangements without relying on broad assurances.
How should condition-specific marketing be approached?
Separate a clinic’s marketing from established evidence. Claims involving alcohol addiction treatment, extreme alcoholism, or depression treatment should be checked against the limits of available research and discussed with appropriately qualified healthcare professionals. This page does not endorse treatment for any condition.
Does the source or name of a substance answer the safety question?
No. Discussions of ibogaine-containing plants or comparisons such as ibogaine and ayahuasca terminology do not establish suitability, product quality, legal status, screening needs, or emergency readiness. Return to the practical questions: what is documented, who is responsible, and what happens if something goes wrong?
For a broader orientation before comparing overseas options, use the Cautious Aperture starting point and keep legal and safety considerations in view.